Emerging Science in Generalized Myasthenia Gravis: Telitacicept with Melanie Taylor, MD

Join us with special guest Melanie Taylor, MD, Medical Director of the Trinity Health Hauenstein Neuroscience Neuromuscular Program, as she presents on Emerging Science in Generalized Myasthenia Gravis: Telitacicept. You will discover:

• How telitacicept works in a different way from other current therapies by targeting key immune signaling proteins that play a part in the production of MG-causing antibodies
• Available data from clinical studies of telitacicept in patients with gMG
• Details around an ongoing, currently enrolling global clinical trial of telitacicept in patients with gMG that includes study sites in the US

This is a great opportunity to learn, share, and connect.

Register in advance for this meeting:
https://us02web.zoom.us/meeting/register/OEy8Qh5ZTQGD4_a8nV_saA

After registering, you will receive a confirmation email containing information about joining the meeting.